India lifts export ban on anti-malarial drug hydroxychloroquine

The Centre on Thursday lifted the export ban on anti-malarial drug hydroxychloroquine with immediate effect. The government on March 25 had banned the export of the drug in the wake of the outbreak of coronavirus COVID-19 pandemic.

"The export policy of Hydroxychloroquine API (active pharmaceutical ingredients) and its formulations from prohibited to free with immediate effect," the Directorate General of Foreign Trade (DFFT) said in a notification.